Clinical Trial Update: Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing FORRAD with Biafine (trolamine) for management of radiation dermatitis in patients with nasopharyngeal carcinoma undergoing IMR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Radiodermatitis

Drugs mentioned

• Biafine (trolamine)
• FORRAD

Snippet

Sponsor: Yun-fei Xia | Conditions: Nasopharyngeal Neoplasms, Radiodermatitis | Phase 2 | Status: UNKNOWN